Experimental characterization of a diamond detection system for combined dose, LET and RBE assessment in clinical proton beams
At a Glance
Section titled āAt a Glanceā| Metadata | Details |
|---|---|
| Publication Date | 2025-09-25 |
| Journal | Physics in Medicine and Biology |
| Authors | C. Verona, Andrea Fabbri, A. Fazzi, Lucrezia Bianchi, Anna Bianchi |
| Institutions | GSI Helmholtz Centre for Heavy Ion Research, Roma Tre University |
Abstract
Section titled āAbstractāAbstract Objective: This work presents the first experimental characterization of the DIODE detector, a novel detection system based on single-crystal diamond, designed for simultaneous dosimetric and microdosimetric measurements in clinical proton therapy. The aim is to evaluate its capability to measure absorbed dose, and estimate LET and RBE variations along a clinical proton beam.
 Approach: The detector was tested under a 70 MeV monoenergetic proton beam at the Trento Proton Therapy Centre. Depth-dose and lateral profiles were compared with EBT3 radiochromic films. Microdosimetric spectra were simultaneously acquired and benchmarked against a mini tissue-equivalent proportional counter (TEPC). Monte Carlo (MC) simulations were also performed to model the experimental setup and the DIODE geometry.
 Main results: The detector showed linearity with dose with a sensitivity of 0.60 Ā± 0.01 nC/Gy, with a dark current below 0.1 pA, ensuring a good signal-to-noise ratio. Depth-dose profiles matched EBT3 film data and MC simulations, with differences below 2% in peak-to-plateau ratios, indicating limited LET dependence.
The dose-mean lineal energy y D closely agrees with simulated dose-averaged LET values, except in the beam entrance region. In this area, y D values were lower than those obtained with the mini-TEPC due to electronic saturation limiting the detection of rare high-LET secondary fragments.
Variation in RBE was assessed from the microdosimetric data, based on Loncolās weighting function, which refers to clonogenic cell survival. RBE values ranged from ~1.1 at the entrance to ~1.8 in the distal region, consistent with mini-TEPC data and literature RBEāā values for V79 and U89 cells.
Lateral dose and microdosimetric profiles confirmed high spatial resolution and revealed proton energy variations near the Bragg peak.
 Significance: The DIODE detector demonstrated reliable performance for simultaneous dosimetric and microdosimetric characterization of clinical proton beams. Its ability to measure dose, and to support LET and RBE assessment through microdosimetric modelling, in a single device, highlights its potential as an advanced tool for beam quality assessment and biologically optimized treatment planning in proton therapy.
Tech Support
Section titled āTech SupportāOriginal Source
Section titled āOriginal SourceāReferences
Section titled āReferencesā- 2003 - GEANT4āa simulation toolkit [Crossref]
- 2006 - Geant4 developments and applications [Crossref]
- 2016 - Recent developments in GEANT4 [Crossref]
- 2022 - Multi-arrays of 3D cylindrical microdetectors for beam characterization and microdosimetry in proton therapy [Crossref]
- 1998 - RBE-LET relationships for cell inactivation and mutation induced by low energy protons in V79 cells: further results at the LNL facility [Crossref]
- 2023a - Microdosimetry of a 62-MeV clinical proton beam with five detectors [Crossref]
- 2025 - First characterization of a multi-site microdosimeter [Crossref]
- 2021a - The effect of different lower detection thresholds in microdosimetric spectra and their mean values [Crossref]
- 2021b - Repeatability and reproducibility of microdosimetry with a mini-TEPC [Crossref]
- 2024 - Microdosimetric measurements for LET monitoring in proton therapy. The development of engineered mini-TEPCs for clinical applications: first results [Crossref]